Chromatin associated proteins

ABSTRACT

This invention relates to an isolated nucleic acid fragment encoding a chromatin associated protein. The invention also relates to the construction of a chimeric gene encoding all or a portion of the chromatin associated protein, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the chromatin associated protein in a transformed host cell.

[0001] This application claims the benefit of U.S. Provisional Application No. 60/092,841, filed Jul. 14, 1998.

FIELD OF THE INVENTION

[0002] This invention is in the field of plant molecular biology. More specifically, this invention pertains to nucleic acid fragments encoding chromatin associated proteins in plants and seeds.

BACKGROUND OF THE INVENTION

[0003] Reversible acetylation of core histones may play an important role in global transcriptional regulation in eucaryotic cells. Increased histone acetylation has been correlated with increased transcription (Roth et al. (1996) Cell 87:5-8) and conversely, studies suggest that deacteylation is correlated with transcriptional repression (Pazin et al. (1997) Cell 89:325-328). A proposed mechanism of transcriptional regulation by histone deacetylation may involve a histone deacetylase that is linked (via protein-protein interactions) to a sequence specific DNA-bound repressor protein. Transcription repression occurs upon deacetylation of core histone proteins (Pazin et al. (1997) Cell 89:325-328). Precisely how reversible acetylation of core proteins in turn controls gene expression is unknown however, several mechanisms for the regulation of transcription via core acetylation have been proposed by Pazine et al. One model suggests acetylation of histone lysine residues increases the access of transcription factors to the DNA. Another, suggests that acetylation of a lysine residue in a chromatin associated protein (histone or nonhistone) of a provides a signal that is recognized by another factor. Accordingly, the availability of nucleic acid sequences encoding all or a portion of histone deacetylase proteins would facilitate studies to better understand global transcriptional regulation in eucaryotic cells. It would also provide genetic tools for the manipulation of histone deacetylase activity and provide mechanisms to control transcriptional gene regulation in plants.

[0004] Several histone deacetylase proteins from corn, rice, soybean and wheat have been discovered. In the process of characterizing these proteins it was discovered that the histone deacetylase proteins had significantly different amino acid sequences, which suggested that these proteins constute a large family of chromatin associated deacetylase proteins. Several classes of histone deacetylase proteins were characterized (genes 1-4) by sets of conserved amino acid motifs and overall sequence homology. Specific conserved sequence motifs were consistent for each of the protein classes across species.

SUMMARY OF THE INVENTION

[0005] The instant invention relates to isolated nucleic acid fragments encoding chromatin associated proteins. Specifically, this invention concerns an isolated nucleic acid fragment encoding a histone deacetylase gene 3 (HD3) and an isolated nucleic acid fragment that is substantially similar to an isolated nucleic acid fragment encoding a HD3. In addition, this invention relates to a nucleic acid fragment that is complementary to the nucleic acid fragment encoding HD3.

[0006] An additional embodiment of the instant invention pertains to a polypeptide encoding all or a substantial portion of a chromatin associated protein selected from the group consisting of HD3.

[0007] In another embodiment, the instant invention relates to a chimeric gene encoding a HD3 or to a chimeric gene that comprises a nucleic acid fragment that is complementary to a nucleic acid fragment encoding a HD3, operably linked to suitable regulatory sequences, wherein expression of the chimeric gene results in production of levels of the encoded protein in a transformed host cell that is altered (i.e., increased or decreased) from the level produced in an untransformed host cell.

[0008] In a further embodiment, the instant invention concerns a transformed host cell comprising in its genome a chimeric gene encoding a HD3 operably linked to suitable regulatory sequences. Expression of the chimeric gene results in production of altered levels of the encoded protein in the transformed host cell. The transformed host cell can be of eukaryotic or prokaryotic origin, and include cells derived from higher plants and microorganisms. The invention also includes transformed plants that arise from transformed host cells of higher plants, and seeds derived from such transformed plants.

[0009] An additional embodiment of the instant invention concerns a method of altering the level of expression of a HD3 in a transformed host cell comprising: a) transforming a host cell with a chimeric gene comprising a nucleic acid fragment encoding a HD3; and b) growing the transformed host cell under conditions that are suitable for expression of the chimeric gene wherein expression of the chimeric gene results in production of altered levels of HD3 in the transformed host cell.

[0010] An addition embodiment of the instant invention concerns a method for obtaining a nucleic acid fragment encoding all or a substantial portion of an amino acid sequence encoding a HD3.

BRIEF DESCRIPTION OF THE SEQUENCE DESCRIPTIONS

[0011] The invention can be more fully understood from the following detailed description and the accompanying Sequence Listing which form a part of this application.

[0012] Table 1 lists the polypeptides that are described herein, the designation of the cDNA clones that comprise the nucleic acid fragments encoding polypeptides representing all or a substantial portion of these polypeptides, and the corresponding identifier (SEQ ID NO:) as used in the attached Sequence Listing. The sequence descriptions and Sequence Listing attached hereto comply with the rules governing nucleotide and/or amino acid sequence disclosures in patent applications as set forth in 37 C.F.R. §1.821-1.825. TABLE 1 Chromatin Associated Proteins SEQ ID NO: (Amino Protein Clone Designation (Nucleotide) Acid) Histone p0016.ctscg42rb 1 2 Deacetylase Gene 3 rds2c.pk005.d13 3 4 Contig composed of: 5 6 r10n.pk117.n14 rsl1n.pk013.p12 Contig composed of: 7 8 sfl1.pk0071.h1 src3c.pk017.p14

[0013] The Sequence Listing contains the one letter code for nucleotide sequence characters and the three letter codes for amino acids as defined in conformity with the IUPAC-IUBMB standards described in Nucleic Acids Research 13:3021-3030 (1985) and in the Biochemical Journal 219 (No. 2):345-373 (1984) which are herein incorporated by reference. The symbols and format used for nucleotide and amino acid sequence data comply with the rules set forth in 37 C.F.R. §1.822.

DETAILED DESCRIPTION OF THE INVENTION

[0014] In the context of this disclosure, a number of terms shall be utilized. As used herein, a “nucleic acid fragment” is a polymer of RNA or DNA that is single- or double-stranded, optionally containing synthetic, non-natural or altered nucleotide bases. A nucleic acid fragment in the form of a polymer of DNA may be comprised of one or more segments of cDNA, genomic DNA or synthetic DNA.

[0015] As used herein, “contig” refers to a nucleotide sequence that is assembled from two or more constituent nucleotide sequences that share common or overlapping regions of sequence homology. For example, the nucleotide sequences of two or more nucleic acid fragments can be compared and aligned in order to identify common or overlapping sequences. Where common or overlapping sequences exist between two or more nucleic acid fragments, the sequences (and thus their corresponding nucleic acid fragments) can be assembled into a single contiguous nucleotide sequence.

[0016] As used herein, “substantially similar” refers to nucleic acid fragments wherein changes in one or more nucleotide bases results in substitution of one or more amino acids, but do not affect the functional properties of the polypeptide encoded by the nucleotide sequence. “Substantially similar” also refers to nucleic acid fragments wherein changes in one or more nucleotide bases does not affect the ability of the nucleic acid fragment to mediate alteration of gene expression by gene silencing through for example antisense or co-suppression technology. “Substantially similar” also refers to modifications of the nucleic acid fragments of the instant invention such as deletion or insertion of one or more nucleotides that do not substantially affect the functional properties of the resulting transcript vis-a-vis the ability to mediate gene silencing or alteration of the functional properties of the resulting protein molecule. It is therefore understood that the invention encompasses more than the specific exemplary nucleotide or amino acid sequences and includes functional equivalents thereof.

[0017] For example, it is well known in the art that antisense suppression and co-suppression of gene expression may be accomplished using nucleic acid fragments representing less than the entire coding region of a gene, and by nucleic acid fragments that do not share 100% sequence identity with the gene to be suppressed. Moreover, alterations in a nucleic acid fragment which result in the production of a chemically equivalent amino acid at a given site, but do not effect the functional properties of the encoded polypeptide, are well known in the art. Thus, a codon for the amino acid alanine, a hydrophobic amino acid, may be substituted by a codon encoding another less hydrophobic residue, such as glycine, or a more hydrophobic residue, such as valine, leucine, or isoleucine. Similarly, changes which result in substitution of one negatively charged residue for another, such as aspartic acid for glutamic acid, or one positively charged residue for another, such as lysine for arginine, can also be expected to produce a functionally equivalent product. Nucleotide changes which result in alteration of the N-terminal and C-terminal portions of the polypeptide molecule would also not be expected to alter the activity of the polypeptide. Each of the proposed modifications is well within the routine skill in the art, as is determination of retention of biological activity of the encoded products.

[0018] Moreover, substantially similar nucleic acid fragments may also be characterized by their ability to hybridize. Estimates of such homology are provided by either DNA-DNA or DNA-RNA hybridization under conditions of stringency as is well understood by those skilled in the art (Hames and Higgins, Eds. (1985) Nucleic Acid Hybridisation, IRL Press, Oxford, U.K.). Stringency conditions can be adjusted to screen for moderately similar fragments, such as homologous sequences from distantly related organisms, to highly similar fragments, such as genes that duplicate functional enzymes from closely related organisms. Post-hybridization washes determine stringency conditions. One set of preferred conditions uses a series of washes starting with 6× SSC, 0.5% SDS at room temperature for 15 min, then repeated with 2× SSC, 0.5% SDS at 45° C. for 30 min, and then repeated twice with 0.2× SSC, 0.5% SDS at 50° C. for 30 min. A more preferred set of stringent conditions uses higher temperatures in which the washes are identical to those above except for the temperature of the final two 30 min washes in 0.2× SSC, 0.5% SDS was increased to 60° C. Another preferred set of highly stringent conditions uses two final washes in 0.1× SSC, 0.1% SDS at 65° C.

[0019] Substantially similar nucleic acid fragments of the instant invention may also be characterized by the percent identity of the amino acid sequences that they encode to the amino acid sequences disclosed herein, as determined by algorithms commonly employed by those skilled in this art. Preferred are those nucleic acid fragments whose nucleotide sequences encode amino acid sequences that are 80% similar to the amino acid sequences reported herein. More preferred nucleic acid fragments encode amino acid sequences that are 90% similar to the amino acid sequences reported herein. Most preferred are nucleic acid fragments that encode amino acid sequences that are 95% similar to the amino acid sequences reported herein. Sequence alignments and percent similarity calculations were performed using the Megalign program of the LASARGENE bioinformatics computing suite (DNASTAR Inc., Madison, Wis.). Multiple alignment of the sequences was performed using the Clustal method of alignment (Higgins and Sharp (1989) CABIOS. 5:151-153) with the default parameters (GAP PENALTY=10, GAP LENGTH PENALTY=10). Default parameters for pairwise alignments using the Clustal method were KTUPLE 1, GAP PENALTY=3, WINDOW=5 and DIAGONALS SAVED=5.

[0020] A “substantial portion” of an amino acid or nucleotide sequence comprises an amino acid or a nucleotide sequence that is sufficient to afford putative identification of the protein or gene that the amino acid or nucleotide sequence comprises. Amino acid and nucleotide sequences can be evaluated either manually by one skilled in the art, or by using computer-based sequence comparison and identification tools that employ algorithms such as BLAST (Basic Local Alignment Search Tool; Altschul et al. (1993) J. Mol. Biol. 215:403-410; see also www.ncbi.nlm.nih.gov/BLAST/). In general, a sequence of ten or more contiguous amino acids or thirty or more contiguous nucleotides is necessary in order to putatively identify a polypeptide or nucleic acid sequence as homologous to a known protein or gene. Moreover, with respect to nucleotide sequences, gene-specific oligonucleotide probes comprising 30 or more contiguous nucleotides may be used in sequence-dependent methods of gene identification (e.g., Southern hybridization) and isolation (e.g., in situ hybridization of bacterial colonies or bacteriophage plaques). In addition, short oligonucleotides of 12 or more nucleotides may be used as amplification primers in PCR in order to obtain a particular nucleic acid fragment comprising the primers. Accordingly, a “substantial portion” of a nucleotide sequence comprises a nucleotide sequence that will afford specific identification and/or isolation of a nucleic acid fragment comprising the sequence. The instant specification teaches amino acid and nucleotide sequences encoding polypeptides that comprise one or more particular plant proteins. The skilled artisan, having the benefit of the sequences as reported herein, may now use all or a substantial portion of the disclosed sequences for purposes known to those skilled in this art. Accordingly, the instant invention comprises the complete sequences as reported in the accompanying Sequence Listing, as well as substantial portions of those sequences as defined above.

[0021] “Codon degeneracy” refers to divergence in the genetic code permitting variation of the nucleotide sequence without effecting the amino acid sequence of an encoded polypeptide. Accordingly, the instant invention relates to any nucleic acid fragment comprising a nucleotide sequence that encodes all or a substantial portion of the amino acid sequences set forth herein. The skilled artisan is well aware of the “codon-bias” exhibited by a specific host cell in usage of nucleotide codons to specify a given amino acid. Therefore, when synthesizing a nucleic acid fragment for improved expression in a host cell, it is desirable to design the nucleic acid fragment such that its frequency of codon usage approaches the frequency of preferred codon usage of the host cell.

[0022] “Synthetic nucleic acid fragments” can be assembled from oligonucleotide building blocks that are chemically synthesized using procedures known to those skilled in the art. These building blocks are ligated and annealed to form larger nucleic acid fragments which may then be enzymatically assembled to construct the entire desired nucleic acid fragment. “Chemically synthesized”, as related to nucleic acid fragment, means that the component nucleotides were assembled in vitro. Manual chemical synthesis of nucleic acid fragments may be accomplished using well established procedures, or automated chemical synthesis can be performed using one of a number of commercially available machines. Accordingly, the nucleic acid fragments can be tailored for optimal gene expression based on optimization of nucleotide sequence to reflect the codon bias of the host cell. The skilled artisan appreciates the likelihood of successful gene expression if codon usage is biased towards those codons favored by the host. Determination of preferred codons can be based on a survey of genes derived from the host cell where sequence information is available.

[0023] “Gene” refers to a nucleic acid fragment that expresses a specific protein, including regulatory sequences preceding (5′ non-coding sequences) and following (3′ non-coding sequences) the coding sequence. “Native gene” refers to a gene as found in nature with its own regulatory sequences. “Chimeric gene” refers any gene that is not a native gene, comprising regulatory and coding sequences that are not found together in nature. Accordingly, a chimeric gene may comprise regulatory sequences and coding sequences that are derived from different sources, or regulatory sequences and coding sequences derived from the same source, but arranged in a manner different than that found in nature. “Endogenous gene” refers to a native gene in its natural location in the genome of an organism. A “foreign” gene refers to a gene not normally found in the host organism, but that is introduced into the host organism by gene transfer. Foreign genes can comprise native genes inserted into a non-native organism, or chimeric genes. A “transgene” is a gene that has been introduced into the genome by a transformation procedure.

[0024] “Coding sequence” refers to a nucleotide sequence that codes for a specific amino acid sequence. “Regulatory sequences” refer to nucleotide sequences located upstream (5′ non-coding sequences), within, or downstream (3′ non-coding sequences) of a coding sequence, and which influence the transcription, RNA processing or stability, or translation of the associated coding sequence. Regulatory sequences may include promoters, translation leader sequences, introns, and polyadenylation recognition sequences.

[0025] “Promoter” refers to a nucleotide sequence capable of controlling the expression of a coding sequence or functional RNA. In general, a coding sequence is located 3′ to a promoter sequence. The promoter sequence consists of proximal and more distal upstream elements, the latter elements often referred to as enhancers. Accordingly, an “enhancer” is a nucleotide sequence which can stimulate promoter activity and may be an innate element of the promoter or a heterologous element inserted to enhance the level or tissue-specificity of a promoter. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even comprise synthetic nucleotide segments. It is understood by those skilled in the art that different promoters may direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental conditions. Promoters which cause a nucleic acid fragment to be expressed in most cell types at most times are commonly referred to as “constitutive promoters”. New promoters of various types useful in plant cells are constantly being discovered; numerous examples may be found in the compilation by Okamuro and Goldberg (1989) Biochemistry of Plants 15:1-82. It is further recognized that since in most cases the exact boundaries of regulatory sequences have not been completely defined, nucleic acid fragments of different lengths may have identical promoter activity.

[0026] The “translation leader sequence” refers to a nucleotide sequence located between the promoter sequence of a gene and the coding sequence. The translation leader sequence is present in the fully processed mRNA upstream of the translation start sequence. The translation leader sequence may affect processing of the primary transcript to mRNA, mRNA stability or translation efficiency. Examples of translation leader sequences have been described (Turner and Foster (1995) Molecular Biotechnology 3:225).

[0027] The “3′ non-coding sequences” refer to nucleotide sequences located downstream of a coding sequence and include polyadenylation recognition sequences and other sequences encoding regulatory signals capable of affecting mRNA processing or gene expression. The polyadenylation signal is usually characterized by affecting the addition of polyadenylic acid tracts to the 3′ end of the mRNA precursor. The use of different 3′ non-coding sequences is exemplified by Ingelbrecht et al. (1989) Plant Cell 1:671-680.

[0028] “RNA transcript” refers to the product resulting from RNA polymerase-catalyzed transcription of a DNA sequence. When the RNA transcript is a perfect complementary copy of the DNA sequence, it is referred to as the primary transcript or it may be a RNA sequence derived from posttranscriptional processing of the primary transcript and is referred to as the mature RNA. “Messenger RNA (mRNA)” refers to the RNA that is without introns and that can be translated into polypeptide by the cell. “cDNA” refers to a double-stranded DNA that is complementary to and derived from mRNA. “Sense” RNA refers to an RNA transcript that includes the mRNA and so can be translated into a polypeptide by the cell. “Antisense RNA” refers to an RNA transcript that is complementary to all or part of a target primary transcript or mRNA and that blocks the expression of a target gene (see U.S. Pat. No. 5,107,065, incorporated herein by reference). The complementarity of an antisense RNA may be with any part of the specific nucleotide sequence, i.e., at the 5′ non-coding sequence, 3′ non-coding sequence, introns, or the coding sequence. “Functional RNA” refers to sense RNA, antisense RNA, ribozyme RNA, or other RNA that may not be translated but yet has an effect on cellular processes.

[0029] The term “operably linked” refers to the association of two or more nucleic acid fragments on a single nucleic acid fragment so that the function of one is affected by the other. For example, a promoter is operably linked with a coding sequence when it is capable of affecting the expression of that coding sequence (i.e., that the coding sequence is under the transcriptional control of the promoter). Coding sequences can be operably linked to regulatory sequences in sense or antisense orientation.

[0030] The term “expression”, as used herein, refers to the transcription and stable accumulation of sense (mRNA) or antisense RNA derived from the nucleic acid fragment of the invention. Expression may also refer to translation of mRNA into a polypeptide. “Antisense inhibition” refers to the production of antisense RNA transcripts capable of suppressing the expression of the target protein. “Overexpression” refers to the production of a gene product in transgenic organisms that exceeds levels of production in normal or non-transformed organisms. “Co-suppression” refers to the production of sense RNA transcripts capable of suppressing the expression of identical or substantially similar foreign or endogenous genes (U.S. Pat. No. 5,231,020, incorporated herein by reference).

[0031] “Altered levels” refers to the production of gene product(s) in transgenic organisms in amounts or proportions that differ from that of normal or non-transformed organisms.

[0032] “Mature” protein refers to a post-translationally processed polypeptide; i.e., one from which any pre- or propeptides present in the primary translation product have been removed. “Precursor” protein refers to the primary product of translation of mRNA; i.e., with pre- and propeptides still present. Pre- and propeptides may be but are not limited to intracellular localization signals.

[0033] A “chloroplast transit peptide” is an amino acid sequence which is translated in conjunction with a protein and directs the protein to the chloroplast or other plastid types present in the cell in which the protein is made. “Chloroplast transit sequence” refers to a nucleotide sequence that encodes a chloroplast transit peptide. A “signal peptide” is an amino acid sequence which is translated in conjunction with a protein and directs the protein to the secretory system (Chrispeels (1991) Ann. Rev. Plant Phys. Plant Mol. Biol. 42:21-53). If the protein is to be directed to a vacuole, a vacuolar targeting signal (supra) can further be added, or if to the endoplasmic reticulum, an endoplasmic reticulum retention signal (supra) may be added. If the protein is to be directed to the nucleus, any signal peptide present should be removed and instead a nuclear localization signal included (Raikhel (1992) Plant Phys. 100:1627-1632).

[0034] “Transformation” refers to the transfer of a nucleic acid fragment into the genome of a host organism, resulting in genetically stable inheritance. Host organisms containing the transformed nucleic acid fragments are referred to as “transgenic” organisms. Examples of methods of plant transformation include Agrobacterium-mediated transformation (De Blaere et al. (1987) Meth. Enzymol. 143:277) and particle-accelerated or “gene gun” transformation technology (Klein et al. (1987) Nature (London) 327:70-73; U.S. Pat. No. 4,945,050, incorporated herein by reference).

[0035] Standard recombinant DNA and molecular cloning techniques used herein are well known in the art and are described more fully in Sambrook et al. Molecular Cloning: A Laboratory Manual; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989 (hereinafter “Maniatis”).

[0036] Nucleic acid fragments encoding at least a portion of several chromatin associated proteins have been isolated and identified by comparison of random plant cDNA sequences to public databases containing nucleotide and protein sequences using the BLAST algorithms well known to those skilled in the art. The nucleic acid fragments of the instant invention may be used to isolate cDNAs and genes encoding homologous proteins from the same or other plant species. Isolation of homologous genes using sequence-dependent protocols is well known in the art. Examples of sequence-dependent protocols include, but are not limited to, methods of nucleic acid hybridization, and methods of DNA and RNA amplification as exemplified by various uses of nucleic acid amplification technologies (e.g., polymerase chain reaction, ligase chain reaction).

[0037] For example, genes encoding other HD3 proteins, either as cDNAs or genomic DNAs, could be isolated directly by using all or a portion of the instant nucleic acid fragments as DNA hybridization probes to screen libraries from any desired plant employing methodology well known to those skilled in the art. Specific oligonucleotide probes based upon the instant nucleic acid sequences can be designed and synthesized by methods known in the art (Maniatis). Moreover, the entire sequences can be used directly to synthesize DNA probes by methods known to the skilled artisan such as random primer DNA labeling, nick translation, or end-labeling techniques, or RNA probes using available in vitro transcription systems. In addition, specific primers can be designed and used to amplify a part or all of the instant sequences. The resulting amplification products can be labeled directly during amplification reactions or labeled after amplification reactions, and used as probes to isolate full length cDNA or genomic fragments under conditions of appropriate stringency.

[0038] In addition, two short segments of the instant nucleic acid fragments may be used in polymerase chain reaction protocols to amplify longer nucleic acid fragments encoding homologous genes from DNA or RNA. The polymerase chain reaction may also be performed on a library of cloned nucleic acid fragments wherein the sequence of one primer is derived from the instant nucleic acid fragments, and the sequence of the other primer takes advantage of the presence of the polyadenylic acid tracts to the 3′ end of the mRNA precursor encoding plant genes. Alternatively, the second primer sequence may be based upon sequences derived from the cloning vector. For example, the skilled artisan can follow the RACE protocol (Frohman et al. (1988) Proc. Natl. Acad. Sci. USA 85:8998) to generate cDNAs by using PCR to amplify copies of the region between a single point in the transcript and the 3′ or 5′ end. Primers oriented in the 3′ and 5′ directions can be designed from the instant sequences. Using commercially available 3′ RACE or 5′ RACE systems (BRL), specific 3′ or 5′ cDNA fragments can be isolated (Ohara et al. (1989) Proc. Natl. Acad. Sci. USA 86:5673; Loh et al. (1989) Science 243:217). Products generated by the 3′ and 5′ RACE procedures can be combined to generate full-length cDNAs (Frohman and Martin (1989) Techniques 1:165).

[0039] Availability of the instant nucleotide and deduced amino acid sequences facilitates immunological screening of cDNA expression libraries. Synthetic peptides representing portions of the instant amino acid sequences may be synthesized. These peptides can be used to immunize animals to produce polyclonal or monoclonal antibodies with specificity for peptides or proteins comprising the amino acid sequences. These antibodies can be then be used to screen cDNA expression libraries to isolate full-length cDNA clones of interest (Lerner (1984) Adv. Immunol. 36:1; Maniatis).

[0040] The nucleic acid fragments of the instant invention may be used to create transgenic plants in which the disclosed polypeptides are present at higher or lower levels than normal or in cell types or developmental stages in which they are not normally found. This would have the effect of altering the level of histone acetylation in those cells which in turn could alter global gene expression.

[0041] Overexpression of the proteins of the instant invention may be accomplished by first constructing a chimeric gene in which the coding region is operably linked to a promoter capable of directing expression of a gene in the desired tissues at the desired stage of development. For reasons of convenience, the chimeric gene may comprise promoter sequences and translation leader sequences derived from the same genes. 3′ Non-coding sequences encoding transcription termination signals may also be provided. The instant chimeric gene may also comprise one or more introns in order to facilitate gene expression.

[0042] Plasmid vectors comprising the instant chimeric gene can then constructed. The choice of plasmid vector is dependent upon the method that will be used to transform host plants. The skilled artisan is well aware of the genetic elements that must be present on the plasmid vector in order to successfully transform, select and propagate host cells containing the chimeric gene. The skilled artisan will also recognize that different independent transformation events will result in different levels and patterns of expression (Jones et al. (1985) EMBO J. 4:2411-2418; De Almeida et al. (1989) Mol. Gen. Genetics 218:78-86), and thus that multiple events must be screened in order to obtain lines displaying the desired expression level and pattern. Such screening may be accomplished by Southern analysis of DNA, Northern analysis of mRNA expression, Western analysis of protein expression, or phenotypic analysis.

[0043] For some applications it may be useful to direct the instant polypeptides to different cellular compartments, or to facilitate its secretion from the cell. It is thus envisioned that the chimeric gene described above may be further supplemented by altering the coding sequence to encode the instant polypeptides with appropriate intracellular targeting sequences such as transit sequences (Keegstra (1989) Cell 56:247-253), signal sequences or sequences encoding endoplasmic reticulum localization (Chrispeels (1991) Ann. Rev. Plant Phys. Plant Mol. Biol. 42:21-53), or nuclear localization signals (Raikhel (1992) Plant Phys. 100:1627-1632) added and/or with targeting sequences that are already present removed. While the references cited give examples of each of these, the list is not exhaustive and more targeting signals of utility may be discovered in the future.

[0044] It may also be desirable to reduce or eliminate expression of genes encoding the instant polypeptides in plants for some applications. In order to accomplish this, a chimeric gene designed for co-suppression of the instant polypeptide can be constructed by linking a gene or gene fragment encoding that polypeptide to plant promoter sequences. Alternatively, a chimeric gene designed to express antisense RNA for all or part of the instant nucleic acid fragment can be constructed by linking the gene or gene fragment in reverse orientation to plant promoter sequences. Either the co-suppression or antisense chimeric genes could be introduced into plants via transformation wherein expression of the corresponding endogenous genes are reduced or eliminated.

[0045] Molecular genetic solutions to the generation of plants with altered gene expression have a decided advantage over more traditional plant breeding approaches. Changes in plant phenotypes can be produced by specifically inhibiting expression of one or more genes by antisense inhibition or cosuppression (U.S. Pat. Nos. 5,190,931, 5,107,065 and 5,283,323). An antisense or cosuppression construct would act as a dominant negative regulator of gene activity. While conventional mutations can yield negative regulation of gene activity these effects are most likely recessive. The dominant negative regulation available with a transgenic approach may be advantageous from a breeding perspective. In addition, the ability to restrict the expression of specific phenotype to the reproductive tissues of the plant by the use of tissue specific promoters may confer agronomic advantages relative to conventional mutations which may have an effect in all tissues in which a mutant gene is ordinarily expressed.

[0046] The person skilled in the art will know that special considerations are associated with the use of antisense or cosuppresion technologies in order to reduce expression of particular genes. For example, the proper level of expression of sense or antisense genes may require the use of different chimeric genes utilizing different regulatory elements known to the skilled artisan. Once transgenic plants are obtained by one of the methods described above, it will be necessary to screen individual transgenics for those that most effectively display the desired phenotype. Accordingly, the skilled artisan will develop methods for screening large numbers of transformants. The nature of these screens will generally be chosen on practical grounds, and is not an inherent part of the invention. For example, one can screen by looking for changes in gene expression by using antibodies specific for the protein encoded by the gene being suppressed, or one could establish assays that specifically measure enzyme activity. A preferred method will be one which allows large numbers of samples to be processed rapidly, since it will be expected that a large number of transformants will be negative for the desired phenotype.

[0047] The instant polypeptides (or portions thereof) may be produced in heterologous host cells, particularly in the cells of microbial hosts, and can be used to prepare antibodies to the these proteins by methods well known to those skilled in the art. The antibodies are useful for detecting the polypeptides of the instant invention in situ in cells or in vitro in cell extracts. Preferred heterologous host cells for production of the instant polypeptides are microbial hosts. Microbial expression systems and expression vectors containing regulatory sequences that direct high level expression of foreign proteins are well known to those skilled in the art. Any of these could be used to construct a chimeric gene for production of the instant polypeptides. This chimeric gene could then be introduced into appropriate microorganisms via transformation to provide high level expression of the encoded chromatin associated protein. An example of a vector for high level expression of the instant polypeptides in a bacterial host is provided (Example 6).

[0048] All or a substantial portion of the nucleic acid fragments of the instant invention may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes. For example, the instant nucleic acid fragments may be used as restriction fragment length polymorphism (RFLP) markers. Southern blots (Maniatis) of restriction-digested plant genomic DNA may be probed with the nucleic acid fragments of the instant invention. The resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (Lander et al. (1987) Genomics 1:174-181) in order to construct a genetic map. In addition, the nucleic acid fragments of the instant invention may be used to probe Southern blots containing restriction endonuclease-treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross. Segregation of the DNA polymorphisms is noted and used to calculate the position of the instant nucleic acid sequence in the genetic map previously obtained using this population (Botstein et al. (1980) Am. J. Hum. Genet. 32:314-331).

[0049] The production and use of plant gene-derived probes for use in genetic mapping is described in Bernatzky and Tanksley (1986) Plant Mol. Biol. Reporter 4(1):37-41. Numerous publications describe genetic mapping of specific cDNA clones using the methodology outlined above or variations thereof. For example, F2 intercross populations, backcross populations, randomly mated populations, near isogenic lines, and other sets of individuals may be used for mapping. Such methodologies are well known to those skilled in the art.

[0050] Nucleic acid probes derived from the instant nucleic acid sequences may also be used for physical mapping (i.e., placement of sequences on physical maps; see Hoheisel et al. In: Nonmammalian Genomic Analysis: A Practical Guide, Academic press 1996, pp. 319-346, and references cited therein).

[0051] In another embodiment, nucleic acid probes derived from the instant nucleic acid sequences may be used in direct fluorescence in situ hybridization (FISH) mapping (Trask (1991) Trends Genet. 7:149-154). Although current methods of FISH mapping favor use of large clones (several to several hundred KB; see Laan et al. (1995) Genome Research 5:13-20), improvements in sensitivity may allow performance of FISH mapping using shorter probes.

[0052] A variety of nucleic acid amplification-based methods of genetic and physical mapping may be carried out using the instant nucleic acid sequences. Examples include allele-specific amplification (Kazazian (1989) J. Lab. Clin. Med. 114(2):95-96), polymorphism of PCR-amplified fragments (CAPS; Sheffield et al. (1993) Genomics 16:325-332), allele-specific ligation (Landegren et al. (1988) Science 241:1077-1080), nucleotide extension reactions (Sokolov (1990) Nucleic Acid Res. 18:3671), Radiation Hybrid Mapping (Walter et al. (1997) Nature Genetics 7:22-28) and Happy Mapping (Dear and Cook (1989) Nucleic Acid Res. 17:6795-6807). For these methods, the sequence of a nucleic acid fragment is used to design and produce primer pairs for use in the amplification reaction or in primer extension reactions. The design of such primers is well known to those skilled in the art. In methods employing PCR-based genetic mapping, it may be necessary to identify DNA sequence differences between the parents of the mapping cross in the region corresponding to the instant nucleic acid sequence. This, however, is generally not necessary for mapping methods.

[0053] Loss of function mutant phenotypes may be identified for the instant cDNA clones either by targeted gene disruption protocols or by identifying specific mutants for these genes contained in a maize population carrying mutations in all possible genes (Ballinger and Benzer (1989) Proc. Natl. Acad. Sci USA 86:9402; Koes et al. (1995) Proc. Natl. Acad. Sci USA 92:8149; Bensen et al. (1995) Plant Cell 7:75). The latter approach may be accomplished in two ways. First, short segments of the instant nucleic acid fragments may be used in polymerase chain reaction protocols in conjunction with a mutation tag sequence primer on DNAs prepared from a population of plants in which Mutator transposons or some other mutation-causing DNA element has been introduced (see Bensen, supra). The amplification of a specific DNA fragment with these primers indicates the insertion of the mutation tag element in or near the plant gene encoding the instant polypeptides. Alternatively, the instant nucleic acid fragment may be used as a hybridization probe against PCR amplification products generated from the mutation population using the mutation tag sequence primer in conjunction with an arbitrary genomic site primer, such as that for a restriction enzyme site-anchored synthetic adaptor. With either method, a plant containing a mutation in the endogenous gene encoding the instant polypeptides can be identified and obtained. This mutant plant can then be used to determine or confirm the natural function of the instant polypeptides disclosed herein.

EXAMPLES

[0054] The present invention is further defined in the following Examples, in which all parts and percentages are by weight and degrees are Celsius, unless otherwise stated. It should be understood that these Examples, while indicating preferred embodiments of the invention, are given by way of illustration only. From the above discussion and these Examples, one skilled in the art can ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions.

Example 1 Composition of cDNA Libraries; Isolation and Sequencing of cDNA Clones

[0055] cDNA libraries representing mRNAs from various corn, rice, soybean and wheat tissues were prepared. The characteristics of the libraries are described below. TABLE 2 cDNA Libraries from Corn, Rice, Soybean and Wheat Library Tissue Clone p0016 Corn tassel shoots, 0.1-1.4 cm, pooled p0016.ctscg42rb rds2c Rice developing seeds in the middle of the rds2c.pk005.d13 plant r10n Rice 15 day old leaf* r10n.pk0014.d8 rsl1n Rice 15 day old seedling* rsl1n.pk013.p12 sfl1 Soybean immature flower sfl1.pk0071.h1 src3c Soybean 8 day old root infected with cyst src3c.pk017.p14 nematode, Heterodera glycines

[0056] cDNA libraries may be prepared by any one of many methods available. For example, the cDNAs may be introduced into plasmid vectors by first preparing the cDNA libraries in Uni-ZAP* XR vectors according to the manufacturer's protocol (Stratagene Cloning Systems, La Jolla, Calif.). The Uni-ZAP* XR libraries are converted into plasmid libraries according to the protocol provided by Stratagene. Upon conversion, cDNA inserts will be contained in the plasmid vector pBluescript. In addition, the cDNAs may be introduced directly into precut Bluescript II SK(+) vectors (Stratagene) using T4 DNA ligase (New England Biolabs), followed by transfection into DH10B cells according to the manufacturer's protocol (GIBCO BRL Products). Once the cDNA inserts are in plasmid vectors, plasmid DNAs are prepared from randomly picked bacterial colonies containing recombinant pBluescript plasmids, or the insert cDNA sequences are amplified via polymerase chain reaction using primers specific for vector sequences flanking the inserted cDNA sequences. Amplified insert DNAs or plasmid DNAs are sequenced in dye-primer sequencing reactions to generate partial cDNA sequences (expressed sequence tags or “ESTs”; see Adams et al., (1991) Science 252:1651). The resulting ESTs are analyzed using a Perkin Elmer Model 377 fluorescent sequencer.

Example 2 Identification of cDNA Clones

[0057] cDNA clones encoding chromatin associated proteins were identified by conducting BLAST (Basic Local Alignment Search Tool; Altschul et al. (1993) J. Mol. Biol. 215:403-410; see also www.ncbi.nlm.nih.gov/BLAST/) searches for similarity to sequences contained in the BLAST “nr” database (comprising all non-redundant GenBank CDS translations, sequences derived from the 3-dimensional structure Brookhaven Protein Data Bank, the last major release of the SWISS-PROT protein sequence database, EMBL, and DDBJ databases). The cDNA sequences obtained in Example 1 were analyzed for similarity to all publicly available DNA sequences contained in the “nr” database using the BLASTN algorithm provided by the National Center for Biotechnology Information (NCBI). The DNA sequences were translated in all reading frames and compared for similarity to all publicly available protein sequences contained in the “nr” database using the BLASTX algorithm (Gish and States (1993) Nature Genetics 3:266-272) provided by the NCBI. For convenience, the P-value (probability) of observing a match of a cDNA sequence to a sequence contained in the searched databases merely by chance as calculated by BLAST are reported herein as “pLog” values, which represent the negative of the logarithm of the reported P-value. Accordingly, the greater the pLog value, the greater the likelihood that the cDNA sequence and the BLAST “hit” represent homologous proteins.

Example 3 Characterization of cDNA Clones Encoding Histone Deacetylase Gene 3

[0058] The BLASTX search using the EST sequences from clones listed in Table 3 revealed similarity of the polypeptides encoded by the cDNAs to histone deacetylase from Gallus gallus (NCBI Identifier Nos: gi 3023929 and 3023932) and Strongylocentrotus purpuratus (NCBI Identifier No: gi 3023930). Shown in Table 3 are the BLAST results for individual ESTs (“EST”) and contigs assembled from two or more ESTs (“Contig”): TABLE 3 BLAST Results for Sequences Encoding Polypeptides Homologous to Histone Deacetylase Gene 3 Clone Status BLAST pLog Score p0016.ctscg42rb EST 93.00 (gi 3023929) rds2c.pk005.d13 EST 69.40 (gi 3023932) Contig composed of: Contig 14.00 (gi 3023930) r10n.pk117.n14 rsl1n.pk013.p12 Contig composed of: Contig 94.15 (gi 3023930) sfl1.pk0071 h1 src3c.pk017.p14

[0059] The data in Table 4 represents a calculation of the percent identity of the amino acid sequences set forth in SEQ ID NOs: 2, 4, 6 and 8 and the Gallus gallus and Strongylocentrotus purpuratus sequences (SEQ ID NOs: 9, 10 and 11). TABLE 4 Percent Identity of Amino Acid Sequences Deduced From the Nucleotide Sequences of cDNA Clones Encoding Polypeptides Homologous to Histone Deacetylase Gene 3 SEQ ID NO. Percent Identity to 2 54% (gi 3023929) 4 62% (gi 3023932) 6 31% (gi 3023930) 8 66% (gi 3023930)

[0060] Sequence alignments and percent identity calculations were performed using the Megalign program of the LASARGENE bioinformatics computing suite (DNASTAR Inc., Madison, Wis.). Multiple alignment of the sequences was performed using the Clustal method of alignment (Higgins and Sharp (1989) CABIOS. 5:151-153) with the default parameters (GAP PENALTY=10, GAP LENGTH PENALTY=10). Default parameters for pairwise alignments using the Clustal method were KTUPLE 1, GAP PENALTY=3, WINDOW=5 and DIAGONALS SAVED=5. Sequence alignments and BLAST scores and probabilities indicate that the nucleic acid fragments comprising the instant cDNA clones encode a substantial portion of a histone deacetylase gene 3. These sequences represent the first corn, rice and soybean sequences encoding histone deacetylase gene 3.

Example 4 Expression of Chimeric Genes in Monocot Cells

[0061] A chimeric gene comprising a cDNA encoding the instant polypeptides in sense orientation with respect to the maize 27 kD zein promoter that is located 5′ to the cDNA fragment, and the 10 kD zein 3′ end that is located 3′ to the cDNA fragment, can be constructed. The cDNA fragment of this gene may be generated by polymerase chain reaction (PCR) of the cDNA clone using appropriate oligonucleotide primers. Cloning sites (NcoI or SmaI) can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the digested vector pML103 as described below. Amplification is then performed in a standard PCR. The amplified DNA is then digested with restriction enzymes NcoI and SmaI and fractionated on an agarose gel. The appropriate band can be isolated from the gel and combined with a 4.9 kb NcoI-SmaI fragment of the plasmid pML103. Plasmid pML103 has been deposited under the terms of the Budapest Treaty at ATCC (American Type Culture Collection, 10801 University Blvd., Manassas, Va. 20110-2209), and bears accession number ATCC 97366. The DNA segment from pML103 contains a 1.05 kb SalI-NcoI promoter fragment of the maize 27 kD zein gene and a 0.96 kb SmaI-SalI fragment from the 3′ end of the maize 10 kD zein gene in the vector pGem9Zf(+) (Promega). Vector and insert DNA can be ligated at 15° C. overnight, essentially as described (Maniatis). The ligated DNA may then be used to transform E. coli XL1-Blue (Epicurian Coli XL-1 Blue™; Stratagene). Bacterial transformants can be screened by restriction enzyme digestion of plasmid DNA and limited nucleotide sequence analysis using the dideoxy chain termination method (Sequenase T DNA Sequencing Kit; U.S. Biochemical). The resulting plasmid construct would comprise a chimeric gene encoding, in the 5′ to 3′ direction, the maize 27 kD zein promoter, a cDNA fragment encoding the instant polypeptides, and the 10 kD zein 3′ region.

[0062] The chimeric gene described above can then be introduced into corn cells by the following procedure. Immature corn embryos can be dissected from developing caryopses derived from crosses of the inbred corn lines H99 and LH132. The embryos are isolated 10 to 11 days after pollination when they are 1.0 to 1.5 mm long. The embryos are then placed with the axis-side facing down and in contact with agarose-solidified N6 medium (Chu et al. (1975) Sci. Sin. Peking 18:659-668). The embryos are kept in the dark at 27° C. Friable embryogenic callus consisting of undifferentiated masses of cells with somatic proembryoids and embryoids borne on suspensor structures proliferates from the scutellum of these immature embryos. The embryogenic callus isolated from the primary explant can be cultured on N6 medium and sub-cultured on this medium every 2 to 3 weeks.

[0063] The plasmid, p35S/Ac (obtained from Dr. Peter Eckes, Hoechst Ag, Frankfurt, Germany) may be used in transformation experiments in order to provide for a selectable marker. This plasmid contains the Pat gene (see European Patent Publication 0 242 236) which encodes phosphinothricin acetyl transferase (PAT). The enzyme PAT confers resistance to herbicidal glutamine synthetase inhibitors such as phosphinothricin. The pat gene in p35 S/Ac is under the control of the 35S promoter from Cauliflower Mosaic Virus (Odell et al. (1985) Nature 313:810-812) and the 3′ region of the nopaline synthase gene from the T-DNA of the Ti plasmid of Agrobacterium tumefaciens.

[0064] The particle bombardment method (Klein et al. (1987) Nature 327:70-73) may be used to transfer genes to the callus culture cells. According to this method, gold particles (1 μm in diameter) are coated with DNA using the following technique. Ten μg of plasmid DNAs are added to 50 μL of a suspension of gold particles (60 mg per mL). Calcium chloride (50 μL of a 2.5 M solution) and spermidine free base (20 μL of a 1.0 M solution) are added to the particles. The suspension is vortexed during the addition of these solutions. After 10 minutes, the tubes are briefly centrifuged (5 sec at 15,000 rpm) and the supernatant removed. The particles are resuspended in 200 μL of absolute ethanol, centrifuged again and the supernatant removed. The ethanol rinse is performed again and the particles resuspended in a final volume of 30 μL of ethanol. An aliquot (5 μL) of the DNA-coated gold particles can be placed in the center of a Kapton™ flying disc (Bio-Rad Labs). The particles are then accelerated into the corn tissue with a Biolistic™ PDS-1000/He (Bio-Rad Instruments, Hercules Calif.), using a helium pressure of 1000 psi, a gap distance of 0.5 cm and a flying distance of 1.0 cm.

[0065] For bombardment, the embryogenic tissue is placed on filter paper over agarose-solidified N6 medium. The tissue is arranged as a thin lawn and covered a circular area of about 5 cm in diameter. The petri dish containing the tissue can be placed in the chamber of the PDS-1000/He approximately 8 cm from the stopping screen. The air in the chamber is then evacuated to a vacuum of 28 inches of Hg. The macrocarrier is accelerated with a helium shock wave using a rupture membrane that bursts when the He pressure in the shock tube reaches 1000 psi.

[0066] Seven days after bombardment the tissue can be transferred to N6 medium that contains gluphosinate (2 mg per liter) and lacks casein or proline. The tissue continues to grow slowly on this medium. After an additional 2 weeks the tissue can be transferred to fresh N6 medium containing gluphosinate. After 6 weeks, areas of about 1 cm in diameter of actively growing callus can be identified on some of the plates containing the glufosinate-supplemented medium. These calli may continue to grow when sub-cultured on the selective medium.

[0067] Plants can be regenerated from the transgenic callus by first transferring clusters of tissue to N6 medium supplemented with 0.2 mg per liter of 2,4-D. After two weeks the tissue can be transferred to regeneration medium (Fromm et al. (1990) Bio/Technology 8:833-839).

Example 5 Expression of Chimeric Genes in Dicot Cells

[0068] A seed-specific expression cassette composed of the promoter and transcription terminator from the gene encoding the β subunit of the seed storage protein phaseolin from the bean Phaseolus vulgaris (Doyle et al. (1986) J. Biol. Chem. 261:9228-9238) can be used for expression of the instant polypeptides in transformed soybean. The phaseolin cassette includes about 500 nucleotides upstream (5′) from the translation initiation codon and about 1650 nucleotides downstream (3′) from the translation stop codon of phaseolin. Between the 5′ and 3′ regions are the unique restriction endonuclease sites Nco I (which includes the ATG translation initiation codon), Sma I, Kpn I and Xba I. The entire cassette is flanked by Hind III sites.

[0069] The cDNA fragment of this gene may be generated by polymerase chain reaction (PCR) of the cDNA clone using appropriate oligonucleotide primers. Cloning sites can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the expression vector. Amplification is then performed as described above, and the isolated fragment is inserted into a pUC18 vector carrying the seed expression cassette.

[0070] Soybean embroys may then be transformed with the expression vector comprising sequences encoding the instant polypeptides. To induce somatic embryos, cotyledons, 3-5 mm in length dissected from surface sterilized, immature seeds of the soybean cultivar A2872, can be cultured in the light or dark at 26° C. on an appropriate agar medium for 6-10 weeks. Somatic embryos which produce secondary embryos are then excised and placed into a suitable liquid medium. After repeated selection for clusters of somatic embryos which multiplied as early, globular staged embryos, the suspensions are maintained as described below.

[0071] Soybean embryogenic suspension cultures can maintained in 35 mL liquid media on a rotary shaker, 150 rpm, at 26° C. with florescent lights on a 16:8 hour day/night schedule. Cultures are subcultured every two weeks by inoculating approximately 35 mg of tissue into 35 mL of liquid medium.

[0072] Soybean embryogenic suspension cultures may then be transformed by the method of particle gun bombardment (Klein et al. (1987) Nature (London) 327:70, U.S. Pat. No. 4,945,050). A DuPont Biolistic™ PDS 1000/HE instrument (helium retrofit) can be used for these transformations.

[0073] A selectable marker gene which can be used to facilitate soybean transformation is a chimeric gene composed of the 35S promoter from Cauliflower Mosaic Virus (Odell et al. (1985) Nature 313:810-812), the hygromycin phosphotransferase gene from plasmid pJR225 (from E. coli; Gritz et al. (1983) Gene 25:179-188) and the 3′ region of the nopaline synthase gene from the T-DNA of the Ti plasmid of Agrobacterium tumefaciens. The seed expression cassette comprising the phaseolin 5′ region, the fragment encoding the instant polypeptides and the phaseolin 3′ region can be isolated as a restriction fragment. This fragment can then be inserted into a unique restriction site of the vector carrying the marker gene.

[0074] To 50 μL of a 60 mg/mL 1 μm gold particle suspension is added (in order): 5 μL DNA (1 μg/μL), 20 μl spermidine (0.1 M), and 50 μL CaCl₂ (2.5 M). The particle preparation is then agitated for three minutes, spun in a microfuge for 10 seconds and the supernatant removed. The DNA-coated particles are then washed once in 400 μL 70% ethanol and resuspended in 40 μL of anhydrous ethanol. The DNA/particle suspension can be sonicated three times for one second each. Five μL of the DNA-coated gold particles are then loaded on each macro carrier disk.

[0075] Approximately 300-400 mg of a two-week-old suspension culture is placed in an empty 60×15 mm petri dish and the residual liquid removed from the tissue with a pipette. For each transformation experiment, approximately 5-10 plates of tissue are normally bombarded. Membrane rupture pressure is set at 1100 psi and the chamber is evacuated to a vacuum of 28 inches mercury. The tissue is placed approximately 3.5 inches away from the retaining screen and bombarded three times. Following bombardment, the tissue can be divided in half and placed back into liquid and cultured as described above.

[0076] Five to seven days post bombardment, the liquid media may be exchanged with fresh media, and eleven to twelve days post bombardment with fresh media containing 50 mg/mL hygromycin. This selective media can be refreshed weekly. Seven to eight weeks post bombardment, green, transformed tissue may be observed growing from untransformed, necrotic embryogenic clusters. Isolated green tissue is removed and inoculated into individual flasks to generate new, clonally propagated, transformed embryogenic suspension cultures. Each new line may be treated as an independent transformation event. These suspensions can then be subcultured and maintained as clusters of immature embryos or regenerated into whole plants by maturation and germination of individual somatic embryos.

Example 6 Expression of Chimeric Genes in Microbial Cells

[0077] The cDNAs encoding the instant polypeptides can be inserted into the T7 E. coli expression vector pBT430. This vector is a derivative of pET-3a (Rosenberg et al. (1987) Gene 56:125-135) which employs the bacteriophage T7 RNA polymerase/T7 promoter system. Plasmid pBT430 was constructed by first destroying the EcoR I and Hind III sites in pET-3a at their original positions. An oligonucleotide adaptor containing EcoR I and Hind III sites was inserted at the BamH I site of pET-3a. This created pET-3aM with additional unique cloning sites for insertion of genes into the expression vector. Then, the Nde I site at the position of translation initiation was converted to an Nco I site using oligonucleotide-directed mutagenesis. The DNA sequence of pET-3aM in this region, 5′-CATATGG, was converted to 5′-CCCATGG in pBT430.

[0078] Plasmid DNA containing a cDNA may be appropriately digested to release a nucleic acid fragment encoding the protein. This fragment may then be purified on a 1% NuSieve GTG™ low melting agarose gel (FMC). Buffer and agarose contain 10 μg/ml ethidium bromide for visualization of the DNA fragment. The fragment can then be purified from the agarose gel by digestion with GELase™ (Epicentre Technologies) according to the manufacturer's instructions, ethanol precipitated, dried and resuspended in 20 μL of water. Appropriate oligonucleotide adapters may be ligated to the fragment using T4 DNA ligase (New England Biolabs, Beverly, Mass.). The fragment containing the ligated adapters can be purified from the excess adapters using low melting agarose as described above. The vector pBT430 is digested, dephosphorylated with alkaline phosphatase (NEB) and deproteinized with phenol/chloroform as described above. The prepared vector pBT430 and fragment can then be ligated at 16° C. for 15 hours followed by transformation into DH5 electrocompetent cells (GIBCO BRL). Transformants can be selected on agar plates containing LB media and 100 μg/mL ampicillin. Transformants containing the gene encoding the instant polypeptides are then screened for the correct orientation with respect to the T7 promoter by restriction enzyme analysis.

[0079] For high level expression, a plasmid clone with the cDNA insert in the correct orientation relative to the T7 promoter can be transformed into E. coli strain BL21(DE3) (Studier et al. (1986) J. Mol. Biol. 189:113-130). Cultures are grown in LB medium containing ampicillin (100 mg/L) at 25° C. At an optical density at 600 nm of approximately 1, IPTG (isopropylthio-β-galactoside, the inducer) can be added to a final concentration of 0.4 mM and incubation can be continued for 3 h at 25°. Cells are then harvested by centrifugation and re-suspended in 50 μL of 50 mM Tris-HCl at pH 8.0 containing 0.1 mM DTT and 0.2 mM phenyl methylsulfonyl fluoride. A small amount of 1 mm glass beads can be added and the mixture sonicated 3 times for about 5 seconds each time with a microprobe sonicator. The mixture is centrifuged and the protein concentration of the supernatant determined. One μg of protein from the soluble fraction of the culture can be separated by SDS-polyacrylamide gel electrophoresis. Gels can be observed for protein bands migrating at the expected molecular weight.

1 11 1 1056 DNA Zea mays 1 ccacgcgtcc gctcaagtac catgccaggg ttctttatat tgacattgat gtccatcatg 60 gagatggagt tgaagaagcc ttttatttca ctgacagggt aatgactgtg agtttccaca 120 agtatggtga cctgttcttt cctggaacag gtgatattaa ggatatagga gaaagggaag 180 gaaaatatta tgccatcaac attccactta aagatgggat agatgacact agctttactc 240 ggctttttaa aacaattatt gccaaagttg ttgagacata tctgcctggt gctattgttc 300 ttcaatgtgg ggctgattca ttggcgaggg atcgtttagg ctgcttcaat ctctctattg 360 aaggccatgc tgaatgtgta aagtttgtca agaaattcaa tattcccctt ctggtaactg 420 gaggtggtgg atacaccaag gagaatgtag cacggtgttg ggctgttgaa actggggtcc 480 ttttagacac agaactccca aatgagattc caaaaaatga atatattgag tactttgctc 540 caggattata cattgaaagt tccaaatttg agacatggag caatttgaac agtaagacct 600 atctcagttc aatcaaagtg caagtgatgg agagtttgcg gtacatacag catgctcctg 660 gtgttcaaat gcaagaggtt cctcccgatt tttatatccc ggactttgat gaagatgaat 720 tggatcctga tgaacgtgtt gaccagcaca ctcaagacaa gcagattcac cgtgatgatg 780 agtactatga aggtgacaat gacaacgatc acgacgacgg cacacgctaa tctgcttctt 840 ctgaggccct ggtgtaaatg gaaacctgag attcttcact gttgtgtgta gttcagcagc 900 cttgagatgt aatagtttgt cagttgacag cagggatcta atttagcagg tcaaagtggt 960 ttagactttt ataagggatt ctgacccctc ctgaattaca cattgtagta caagtctgca 1020 tatttttaag catgcaaaaa ttcaaatttc tcaaaa 1056 2 275 PRT Zea mays 2 Thr Arg Pro Leu Lys Tyr His Ala Arg Val Leu Tyr Ile Asp Ile Asp 1 5 10 15 Val His His Gly Asp Gly Val Glu Glu Ala Phe Tyr Phe Thr Asp Arg 20 25 30 Val Met Thr Val Ser Phe His Lys Tyr Gly Asp Leu Phe Phe Pro Gly 35 40 45 Thr Gly Asp Ile Lys Asp Ile Gly Glu Arg Glu Gly Lys Tyr Tyr Ala 50 55 60 Ile Asn Ile Pro Leu Lys Asp Gly Ile Asp Asp Thr Ser Phe Thr Arg 65 70 75 80 Leu Phe Lys Thr Ile Ile Ala Lys Val Val Glu Thr Tyr Leu Pro Gly 85 90 95 Ala Ile Val Leu Gln Cys Gly Ala Asp Ser Leu Ala Arg Asp Arg Leu 100 105 110 Gly Cys Phe Asn Leu Ser Ile Glu Gly His Ala Glu Cys Val Lys Phe 115 120 125 Val Lys Lys Phe Asn Ile Pro Leu Leu Val Thr Gly Gly Gly Gly Tyr 130 135 140 Thr Lys Glu Asn Val Ala Arg Cys Trp Ala Val Glu Thr Gly Val Leu 145 150 155 160 Leu Asp Thr Glu Leu Pro Asn Glu Ile Pro Lys Asn Glu Tyr Ile Glu 165 170 175 Tyr Phe Ala Pro Gly Leu Tyr Ile Glu Ser Ser Lys Phe Glu Thr Trp 180 185 190 Ser Asn Leu Asn Ser Lys Thr Tyr Leu Ser Ser Ile Lys Val Gln Val 195 200 205 Met Glu Ser Leu Arg Tyr Ile Gln His Ala Pro Gly Val Gln Met Gln 210 215 220 Glu Val Pro Pro Asp Phe Tyr Ile Pro Asp Phe Asp Glu Asp Glu Leu 225 230 235 240 Asp Pro Asp Glu Arg Val Asp Gln His Thr Gln Asp Lys Gln Ile His 245 250 255 Arg Asp Asp Glu Tyr Tyr Glu Gly Asp Asn Asp Asn Asp His Asp Asp 260 265 270 Gly Thr Arg 275 3 533 DNA Oryza sativa unsure (13) unsure (22) unsure (26) unsure (54) unsure (56)..(57) unsure (71) unsure (74) unsure (89) unsure (92) unsure (99) 3 cgaacattgc tancaattgg gntggnggga ttgcatcacc gcaaaagaag tgcnanngca 60 tcaaagggtc ngcntacatt aatgatccng gnttttggng aattctggag cttctcaagt 120 accatgccag ggttctctat attgatatcg atgttcatca cggggatgga gttgaagaag 180 ccttttattt cactgacagg gtaatgactg taagtttcca caagtatggt gattttttct 240 tccctggcac aggtgatatt aaggatatag gagaaagaga aggaaaatat tatgccatta 300 acattccact taaagatggg atagatgact ccggctttac tcgccttttt aaaacagtta 360 ttgccaaagt tgttgagaca tatctgccag gtgctattgt tcttcaatgc ggggctgatt 420 ccttggcacg ggaccgtctg gggtgcttca atctgtccat tgaaggccat gctgaatgtg 480 tgaagtttgt caagaaattc aatatccctc tactgggtga ctggggggtg gtg 533 4 171 PRT Oryza sativa UNSURE (4) UNSURE (7) UNSURE (18)..(19) UNSURE (33) 4 Asn Ile Ala Xaa Asn Trp Xaa Gly Gly Ile Ala Ser Pro Gln Lys Lys 1 5 10 15 Cys Xaa Xaa Ile Lys Gly Ser Ala Tyr Ile Asn Asp Pro Gly Phe Trp 20 25 30 Xaa Ile Leu Glu Leu Leu Lys Tyr His Ala Arg Val Leu Tyr Ile Asp 35 40 45 Ile Asp Val His His Gly Asp Gly Val Glu Glu Ala Phe Tyr Phe Thr 50 55 60 Asp Arg Val Met Thr Val Ser Phe His Lys Tyr Gly Asp Phe Phe Phe 65 70 75 80 Pro Gly Thr Gly Asp Ile Lys Asp Ile Gly Glu Arg Glu Gly Lys Tyr 85 90 95 Tyr Ala Ile Asn Ile Pro Leu Lys Asp Gly Ile Asp Asp Ser Gly Phe 100 105 110 Thr Arg Leu Phe Lys Thr Val Ile Ala Lys Val Val Glu Thr Tyr Leu 115 120 125 Pro Gly Ala Ile Val Leu Gln Cys Gly Ala Asp Ser Leu Ala Arg Asp 130 135 140 Arg Leu Gly Cys Phe Asn Leu Ser Ile Glu Gly His Ala Glu Cys Val 145 150 155 160 Lys Phe Val Lys Lys Phe Asn Ile Pro Leu Leu 165 170 5 388 DNA Oryza sativa unsure (69) unsure (138) unsure (244) unsure (299) unsure (313) unsure (353) unsure (362) 5 acgggcgccg ccgccgccgc gctcggtcta atcggaatct atttctcgac gcgactccgc 60 ttccccggnt cccctctcac ccttccgcgc cgccgccgcc gccgcttgta gtggttgggg 120 ggcgagcggc cgctcganag cgaagcgatg ctggagaaaa gacaggatag cctacttcta 180 cgatggcgat gtgggcaatg tctactttgg gccaaatcac ccgatgaaac cacatcgact 240 ttgnatgaca catcatcttg tgctttcata tgatcttcac aagaacgatg ggggatatnt 300 aggccccaca aangcatatc caacagagct cgcacagttc cattctgctg gantaatgtg 360 gnattcttgc atcggctaaa ctcctgac 388 6 49 PRT Oryza sativa UNSURE (7) UNSURE (26) UNSURE (30) UNSURE (44) UNSURE (47) 6 Met Lys Pro His Arg Leu Xaa Met Thr His His Leu Val Leu Ser Tyr 1 5 10 15 Asp Leu His Lys Asn Asp Gly Gly Tyr Xaa Gly Pro Thr Xaa Ala Tyr 20 25 30 Pro Thr Glu Leu Ala Gln Phe His Ser Ala Gly Xaa Met Trp Xaa Ser 35 40 45 Cys 7 741 DNA Glycine max unsure (9) unsure (214) unsure (219) unsure (222) unsure (224) 7 agcacatana gtgattaggc tggtatcaag cgcgacatgg cactgcagtg caggttaagc 60 tcacaccatt gatatcacta gccatattct cctttcgcta attcccgcaa gctactacct 120 tcttcaacgc tctctctgca aaagatgcgc tccaaggaca gaatcgctta cttctacgac 180 ggtgatgtcg gtagtgttta ctttggggcg aagnatccna tnangcccca ccggctttgc 240 atgactcatc atcttgttct ctcatacgat cttcataaga agatggagat ttaccgtcca 300 cacaaggctt atcctgttga gcttgcccag tttcattcag ctgattatgt tgagtttttg 360 aacaggatta cacctgacac tcagcacttg ttcttgaagg aactgacaaa atataatctt 420 ggagaagact gccctgtatt tgacaactta tttgaatttt gtcagattta tgctggtgga 480 actatagatg ctgcacgtcg attaaacaat caattgtgtg atattgctat aaactgggcc 540 ggtggactac atcatgctaa gaaatgcgag gcatctggat tttgttacat caatgacttg 600 gttttaggaa tcttggagct tcttaaatat catgctcgtg ttttgtatat tgatatagat 660 gtgcaccatg gtgatggtgt agaagaagcc ttctacttca ctgacagggt gatgactgtc 720 agttttcaca agtacggaga g 741 8 199 PRT Glycine max UNSURE (24) UNSURE (26)..(27) 8 Met Arg Ser Lys Asp Arg Ile Ala Tyr Phe Tyr Asp Gly Asp Val Gly 1 5 10 15 Ser Val Tyr Phe Gly Ala Lys Xaa Pro Xaa Xaa Pro His Arg Leu Cys 20 25 30 Met Thr His His Leu Val Leu Ser Tyr Asp Leu His Lys Lys Met Glu 35 40 45 Ile Tyr Arg Pro His Lys Ala Tyr Pro Val Glu Leu Ala Gln Phe His 50 55 60 Ser Ala Asp Tyr Val Glu Phe Leu Asn Arg Ile Thr Pro Asp Thr Gln 65 70 75 80 His Leu Phe Leu Lys Glu Leu Thr Lys Tyr Asn Leu Gly Glu Asp Cys 85 90 95 Pro Val Phe Asp Asn Leu Phe Glu Phe Cys Gln Ile Tyr Ala Gly Gly 100 105 110 Thr Ile Asp Ala Ala Arg Arg Leu Asn Asn Gln Leu Cys Asp Ile Ala 115 120 125 Ile Asn Trp Ala Gly Gly Leu His His Ala Lys Lys Cys Glu Ala Ser 130 135 140 Gly Phe Cys Tyr Ile Asn Asp Leu Val Leu Gly Ile Leu Glu Leu Leu 145 150 155 160 Lys Tyr His Ala Arg Val Leu Tyr Ile Asp Ile Asp Val His His Gly 165 170 175 Asp Gly Val Glu Glu Ala Phe Tyr Phe Thr Asp Arg Val Met Thr Val 180 185 190 Ser Phe His Lys Tyr Gly Glu 195 9 480 PRT Gallus gallus 9 Met Ala Leu Thr Gln Gly Thr Lys Arg Lys Val Cys Tyr Tyr Tyr Asp 1 5 10 15 Gly Asp Val Gly Asn Tyr Tyr Tyr Gly Gln Gly His Pro Met Lys Pro 20 25 30 His Arg Ile Arg Met Thr His Asn Leu Leu Leu Asn Tyr Gly Leu Tyr 35 40 45 Arg Lys Met Glu Ile Tyr Arg Pro His Lys Ala Asn Ala Glu Glu Met 50 55 60 Thr Lys Tyr His Ser Asp Asp Tyr Ile Lys Phe Leu Arg Ser Ile Arg 65 70 75 80 Pro Asp Asn Met Ser Glu Tyr Ser Lys Gln Met Gln Arg Phe Asn Val 85 90 95 Gly Glu Asp Cys Pro Val Phe Asp Gly Leu Phe Glu Phe Cys Gln Leu 100 105 110 Ser Ala Gly Gly Ser Val Ala Ser Ala Val Lys Leu Asn Lys Gln Gln 115 120 125 Thr Asp Ile Ala Val Asn Trp Ala Gly Gly Leu His His Ala Lys Lys 130 135 140 Ser Glu Ala Ser Gly Phe Cys Tyr Val Asn Asp Ile Val Leu Ala Ile 145 150 155 160 Leu Glu Leu Leu Lys Tyr His Gln Arg Val Leu Tyr Ile Asp Ile Asp 165 170 175 Ile His His Gly Asp Gly Val Glu Glu Ala Phe Tyr Thr Thr Asp Arg 180 185 190 Val Met Thr Val Ser Phe His Lys Tyr Gly Glu Tyr Phe Pro Gly Thr 195 200 205 Gly Asp Leu Arg Asp Ile Gly Ala Gly Lys Gly Lys Tyr Tyr Ala Val 210 215 220 Asn Tyr Pro Leu Arg Asp Gly Ile Asp Asp Glu Ser Tyr Glu Ala Ile 225 230 235 240 Phe Lys Pro Val Ile Ser Lys Val Met Glu Thr Phe Gln Pro Ser Ala 245 250 255 Val Val Leu Gln Cys Gly Ser Asp Ser Leu Ser Gly Asp Arg Leu Gly 260 265 270 Cys Phe Asn Leu Thr Ile Lys Gly His Ala Lys Cys Val Glu Phe Val 275 280 285 Lys Ser Phe Asn Leu Pro Met Leu Met Leu Gly Gly Gly Gly Tyr Thr 290 295 300 Ile Arg Asn Val Ala Arg Cys Trp Thr Tyr Glu Thr Ala Val Ala Leu 305 310 315 320 Asp Thr Glu Ile Pro Asn Glu Leu Pro Tyr Asn Asp Tyr Phe Glu Tyr 325 330 335 Phe Gly Pro Asp Phe Lys Leu His Ile Ser Pro Ser Asn Met Thr Asn 340 345 350 Gln Asn Thr Asn Glu Tyr Leu Glu Lys Ile Lys Gln Arg Leu Phe Glu 355 360 365 Asn Leu Arg Met Leu Pro His Ala Pro Gly Val Gln Met Gln Pro Ile 370 375 380 Pro Glu Asp Ala Val Gln Glu Asp Ser Gly Asp Glu Glu Glu Glu Asp 385 390 395 400 Pro Glu Lys Arg Ile Ser Ile Arg Asn Ser Asp Lys Arg Ile Ser Cys 405 410 415 Asp Glu Glu Phe Ser Asp Ser Glu Asp Glu Gly Glu Gly Gly Arg Lys 420 425 430 Asn Val Ala Asn Phe Lys Lys Ala Lys Arg Val Lys Thr Glu Glu Glu 435 440 445 Lys Glu Glu Glu Glu Lys Lys Asp Glu Lys Glu Glu Glu Lys Ala Lys 450 455 460 Glu Glu Lys Ala Glu Pro Lys Gly Val Lys Glu Glu Thr Lys Ser Thr 465 470 475 480 10 428 PRT Gallus gallus 10 Met Ala Lys Thr Val Ala Tyr Phe Tyr Asp Pro Asp Val Gly Asn Phe 1 5 10 15 His Tyr Gly Ala Gly His Pro Met Lys Pro His Arg Leu Ala Leu Thr 20 25 30 His Ser Leu Val Leu His Tyr Gly Leu Tyr Lys Lys Met Ile Val Phe 35 40 45 Lys Pro Tyr Gln Ala Ser Gln His Asp Met Cys Arg Phe His Ser Glu 50 55 60 Asp Tyr Ile Asp Phe Leu Gln Arg Val Ser Pro Asn Asn Met Gln Gly 65 70 75 80 Phe Thr Lys Ser Leu Asn Ala Phe Asn Val Gly Asp Asp Cys Pro Val 85 90 95 Phe Pro Gly Leu Phe Glu Phe Cys Ser Arg Tyr Thr Gly Ala Ser Leu 100 105 110 Gln Gly Ala Thr Gln Leu Asn Asn Lys Ile Cys Asp Ile Ala Ile Asn 115 120 125 Trp Ala Gly Gly Leu His His Ala Lys Lys Phe Glu Ala Ser Gly Phe 130 135 140 Cys Tyr Val Asn Asp Ile Val Ile Gly Ile Leu Glu Leu Leu Lys Tyr 145 150 155 160 His Pro Arg Val Leu Tyr Ile Asp Ile Asp Ile His His Gly Asp Gly 165 170 175 Val Gln Glu Ala Phe Tyr Leu Thr Asp Arg Val Met Thr Val Ser Phe 180 185 190 His Lys Tyr Gly Asn Tyr Phe Phe Pro Gly Thr Gly Asp Met Tyr Glu 195 200 205 Val Gly Ala Glu Ser Gly Arg Tyr Tyr Ala Leu Asn Val Pro Leu Arg 210 215 220 Asp Gly Ile Asp Asp Gln Ser Tyr Lys His Leu Phe Gln Pro Val Ile 225 230 235 240 Asn Gln Val Val Asp Tyr Tyr Gln Pro Thr Cys Ile Val Leu Gln Cys 245 250 255 Gly Ala Asp Ser Leu Gly Arg Asp Arg Leu Gly Cys Phe Asn Leu Ser 260 265 270 Ile Arg Gly His Gly Glu Cys Val Glu Tyr Val Lys Ser Phe Asn Ile 275 280 285 Pro Leu Leu Val Leu Gly Gly Gly Gly Tyr Thr Val Arg Asn Val Ala 290 295 300 Arg Cys Trp Thr Tyr Glu Thr Ser Leu Leu Val Asp Glu Ala Ile Ser 305 310 315 320 Glu Glu Leu Pro Tyr Ser Glu Tyr Phe Glu Tyr Phe Ala Pro Asp Phe 325 330 335 Thr Leu His Pro Asp Val Ser Thr Arg Ile Glu Asn Gln Asn Ser Arg 340 345 350 Gln Tyr Leu Asp Gln Ile Arg Gln Thr Ile Phe Glu Asn Leu Lys Met 355 360 365 Leu Asn His Ala Pro Ser Val Gln Ile His Asp Val Pro Ser Asp Leu 370 375 380 Leu Ser Tyr Asp Arg Thr Asp Glu Pro Asp Pro Glu Glu Arg Gly Ser 385 390 395 400 Glu Glu Asn Tyr Ser Arg Pro Glu Ala Ala Asn Glu Phe Tyr Asp Gly 405 410 415 Asp His Asp Asn Asp Lys Glu Ser Asp Val Glu Ile 420 425 11 576 PRT Strongylocentrotus purpuratus 11 Met Ala Ser Thr Gly Thr Lys Lys Arg Val Cys Tyr Tyr Tyr Asp Gly 1 5 10 15 Asp Val Gly Asn Tyr Tyr Tyr Gly Gln Gly His Pro Met Lys Pro His 20 25 30 Arg Ile Arg Met Thr His Asn Leu Ile Leu Asn Tyr Gly Leu Tyr Arg 35 40 45 Lys Met Glu Ile Tyr Arg Pro His Lys Ala Val Met Glu Glu Met Thr 50 55 60 Lys Tyr His Ser Asp Asp Tyr Val Lys Phe Leu Arg Thr Ile Arg Pro 65 70 75 80 Asp Asn Met Ser Glu Tyr Thr Lys Gln Met Gln Arg Phe Asn Val Gly 85 90 95 Glu Asp Cys Pro Val Phe Asp Gly Leu Tyr Glu Phe Cys Gln Leu Ser 100 105 110 Ser Gly Gly Ser Val Ala Gly Ala Val Lys Leu Asn Lys Gln Gln Thr 115 120 125 Asp Ile Ala Ile Asn Trp Ala Gly Gly Leu His His Ala Lys Lys Ser 130 135 140 Glu Ala Ser Gly Phe Cys Tyr Val Asn Asp Ile Val Leu Ala Ile Leu 145 150 155 160 Glu Leu Leu Lys Tyr His Gln Arg Val Leu Tyr Ile Asp Ile Asp Ile 165 170 175 His His Gly Asp Gly Val Glu Glu Ala Phe Tyr Thr Thr Asp Arg Val 180 185 190 Met Thr Val Ser Phe His Lys Tyr Gly Glu Tyr Phe Pro Gly Thr Gly 195 200 205 Asp Leu Arg Asp Ile Gly Ala Gly Lys Gly Lys Tyr Tyr Ala Val Asn 210 215 220 Phe Pro Leu Arg Asp Gly Ile Asp Asp Glu Ser Tyr Asp Lys Ile Phe 225 230 235 240 Lys Pro Ile Met Cys Lys Val Met Glu Met Tyr Gln Pro Ser Ala Ile 245 250 255 Cys Leu Gln Cys Gly Ala Asp Ser Leu Ser Gly Asp Arg Leu Gly Cys 260 265 270 Phe Asn Leu Thr Leu Lys Gly His Ala Lys Cys Val Glu Phe Met Lys 275 280 285 Gln Tyr Asn Leu Pro Leu Leu Leu Met Gly Gly Gly Gly Tyr Thr Ile 290 295 300 Arg Asn Val Ala Arg Cys Trp Thr Tyr Glu Thr Ser Thr Ala Leu Gly 305 310 315 320 Val Glu Ile Ala Asn Glu Leu Pro Tyr Asn Asp Tyr Phe Glu Tyr Phe 325 330 335 Gly Pro Asp Phe Lys Leu His Ile Ser Pro Ser Asn Met Thr Asn Gln 340 345 350 Asn Thr Gly Glu Tyr Leu Asp Lys Ile Lys Thr Arg Leu Tyr Glu Asn 355 360 365 Met Arg Met Ile Pro His Ala Pro Gly Val Gln Met Gln Pro Ile Pro 370 375 380 Glu Asp Ala Ile Pro Asp Asp Ser Asp Ala Glu Asp Glu Ala Glu Asn 385 390 395 400 Pro Asp Lys Arg Ile Ser Ile Met Ala Gln Asp Lys Arg Ile Gln Arg 405 410 415 Asp Asp Glu Phe Ser Asp Ser Glu Asp Glu Gly Glu Thr Arg Leu Pro 420 425 430 Gly Glu Gly Gly Arg Arg Asp His Arg Ser His Lys Ala Lys Arg Ser 435 440 445 Lys Ile Asp Asp Ser Pro Gly Lys Glu Ala Asp Lys Glu Ala Lys Ser 450 455 460 Ser Asp Ala Ser Lys Glu Ala Lys Pro Ala Ala Glu Pro Gln Ala Val 465 470 475 480 Pro Met Asp Thr Thr Pro Ala Pro Pro Pro Lys Lys Ser Glu Asp Lys 485 490 495 Pro Glu Ala Ser Lys Pro Thr Glu Val Lys Ala Lys Pro Ala Glu Lys 500 505 510 Glu Pro Gly Glu Gly Glu Ala Ser Pro Ala Asp Leu Val Val Pro Val 515 520 525 Pro Lys Val Ser Ala Pro Ser Glu Gly Ala Thr Leu Pro Ala Val Thr 530 535 540 Ile Pro Pro Ser Ser Gly Thr Ser Gln Pro Pro Ala Asp Pro Pro Val 545 550 555 560 Ser Ala Pro Thr Pro Thr Pro Ala Ser Ala Pro Ala Glu Lys Gln Asp 565 570 575 

What is claimed is:
 1. An isolated nucleic acid fragment encoding a histone deacetylase 3 protein comprising a member selected from the group consisting of: (a) an isolated nucleic acid fragment encoding the amino acid sequence set forth in a member selected from the group consisting of SEQ ID NO: 2, 4, 6 and 8; (b) an isolated nucleic acid fragment that is complementary to (a).
 2. The isolated nucleic acid fragment of claim 1 wherein nucleic acid fragment is a functional RNA.
 3. The isolated nucleic acid fragment of claim 1 wherein the nucleotide sequence of the fragment comprises the sequence set forth in a member selected from the group consisting of SEQ ID NO: 1, 3, 5 and
 7. 4. A chimeric gene comprising the nucleic acid fragment of claim 1 operably linked to suitable regulatory sequences.
 5. A transformed host cell comprising the chimeric gene of claim 4 .
 6. A histone deacetylase 3 polypeptide comprising the amino acid sequence set forth in a member selected from the group consisting of SEQ ID NO: 2, 4, 6 and
 8. 7. A method of altering the level of expression of a chromatin associated protein in a host cell comprising: (a) transforming a host cell with the chimeric gene comprising a nucleic acid fragment that encodes an amino acid sequence that is at least 90% identical to the amino acid sequence set forth in a member selected from the group consisting of SEQ ID NO: 2, 4, 6 and 8; and (b) growing the transformed host cell produced in step (a) under conditions that are suitable for expression of the chimeric gene wherein expression of the chimeric gene results in production of altered levels of a chromatin associated protein in the transformed host cell.
 8. A method of obtaining a nucleic acid fragment encoding all or a substantial portion of the amino acid sequence encoding a chromatin associated protein comprising: (a) probing a cDNA or genomic library with the nucleic acid fragment of claim 1 ; (b) identifying a DNA clone that hybridizes with the nucleic acid fragment of claim 1 ; (c) isolating the DNA clone identified in step (b); and (d) sequencing the cDNA or genomic fragment that comprises the clone isolated in step (c) wherein the sequenced nucleic acid fragment encodes all or a substantial portion of the amino acid sequence encoding a chromatin associated protein.
 9. A method of obtaining a nucleic acid fragment encoding a substantial portion of an amino acid sequence encoding a chromatin associated protein comprising: (a) synthesizing an oligonucleotide primer corresponding to a portion of the sequence set forth in any of SEQ ID NOs: 1, 3, 5 and 7; and (b) amplifying a cDNA insert present in a cloning vector using the oligonucleotide primer of step (a) and a primer representing sequences of the cloning vector wherein the amplified nucleic acid fragment encodes a substantial portion of an amino acid sequence encoding a chromatin associated protein.
 10. The product of the method of claim 8 .
 11. The product of the method of claim 9 . 